Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype
Biochemical and biological activities of Myc oncoproteins are highly dependent upon their association with another basic region helix-loop-helix/leucine zipper (bHLH/LZ) protein, Max. Our previous observation that the DNA-binding/dimerization region of Max is absolutely conserved throughout vertebra...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 94; no. 4; pp. 1235 - 1240 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences of the United States of America
18-02-1997
National Acad Sciences National Academy of Sciences The National Academy of Sciences of the USA |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Biochemical and biological activities of Myc oncoproteins are highly dependent upon their association with another basic region helix-loop-helix/leucine zipper (bHLH/LZ) protein, Max. Our previous observation that the DNA-binding/dimerization region of Max is absolutely conserved throughout vertebrate evolution provided the basis for a yeast two-hybrid interaction screen that led to the isolation of the Drosophila Myc (dMyc1) protein. Structural conservation in regions of known functional significance is consistent with the ability of dMyc1 to interact with vertebrate Max, to transactivate gene expression in yeast cells, and to cooperate with activated H-RAS to effect the malignant transformation of primary mammalian cells. The ability of P-element-mediated ectopic expression of dmyc1 to reverse a subset of the phenotypic alterations associated with the diminutive mutation suggests that diminutive may correspond to dmyc1. This finding, along with the localization of dmyc1 expression to zones of high proliferative activity in the embryo, implicates dMyc1 as an integral regulator of Drosophila growth and development |
---|---|
Bibliography: | 9731892 L10 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 N.S.-A. and D.S. contributed equally to this work. To whom reprint requests should be addressed. e-mail: depinho@aecom.yu.edu. Frederick Alt, Harvard Medical School, Boston, MA |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.94.4.1235 |